US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist

21.210
-1.070-4.80%

Close Jan 24 16:00 ET

21.210
0.0000.00%

Post 16:00 ET

627.75MMarket Cap-9.28P/E (TTM)

Dianthus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dianthus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 796.000K	--
--	2024/Q4	-- / 859.700K	--
--	2024/Q3	2.172M / 576.440K	--
--	2024/Q2	1.863M / 322.750K	--
--	2024/Q1	874.000K / 371.400K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 796.000K--

--2024/Q4-- / 859.700K--

--2024/Q32.172M / 576.440K--

--2024/Q21.863M / 322.750K--

--2024/Q1874.000K / 371.400K--

Unlock Free Earnings Estimates

Open Account

Dianthus Therapeutics Earnings Reports

Dianthus Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 16:10 ET

Dianthus Therapeutics | 10-Q: Quarterly report

Aug 8, 2024 16:16 ET